Metabolic diseases, including Type 2 Diabetes and obesity, have become 13 increasingly prevalent global health concerns. Studies over the past decade have 14 established connections between the gastrointestinal microbiota and host metabolism, 15 but the mechanisms behind these connections are only beginning to be understood. We 16
Introduction 41
The human gastrointestinal (GI) tract is home to trillions of microorganisms, 42 collectively referred to as the GI microbiome (1) . Because of the direct physical 43 proximity that the gut microbiome has with its human host, it is no surprise that the 44 microbiome plays a role in multiple aspects of health, the best characterized of these 45 being immune tolerance, pathogen resistance, and digestion (2). Less understood are 46 the interactions between the microbiome and human metabolism. Despite limited 47 mechanistic insight into the cross-section of microbiome and host metabolism, it is of 48 great interest as both an etiology of disease and for potential therapeutic applications, 49 and some understanding is beginning to emerge. The first insights into microbial 50 influence over human metabolism came from studies demonstrating that the simple 51 absence of a microbiome resulted in decreased total body fat in germ-free mice, 52 compared to conventional mice, independent of food intake; further, the decrease in fat 53 mass could be gained back by colonizing the germ-free mice with bacterial communities 54 from conventionally raised mice (3). The observed ability of the microbiome to help 55 harvest energy from the diet sparked a variety of research studies over the next decade, 56 6 applied to NCI H716 cell monolayers for 2 h, and secretion of GLP-1 into the medium 87 was measured by ELISA. NCI H716 cell viability was also monitored by PrestoBlue Cell 88 Viability Reagent to ensure no significant increase in NCI H716 cell lysis or death (data 89 not shown). The majority of bacterial isolates screened had no impact on GLP-1 levels; 90 however, approximately 20 isolates showed a marked decrease in GLP-1 levels, many 91 of them below the limit of detection of the ELISA (Figure 1A) . We also identified 45 92
isolates that dramatically increase GLP-1 levels; these were further characterized in a 93 separate study (8) . 94
To identify the species of each isolate, the 16S rRNA gene was sequenced. The 95 majority of the isolates identified as Enterococcus faecalis, as well as Clostridium 96 perfringens, C. bifermentans, and C. butyricum. The E. faecalis isolates exhibited a 97 stronger GLP-1 inhibitory effect, ranging between 0% ± 0.0 and 5.44 ± 9.1% GLP-1, 98 compared to media controls (p < 0.0001, Figure 1B) . The Clostridium species, while still 99 inhibitory, consistently show a slightly weaker inhibitory effect, ranging between 8.0% ± 100 4.6 and 15.2% ± 21.0 GLP-1, compared to media controls (p < 0.0001, Figure 1B) . 101 and S3). These data suggest the factor responsible for GLP-1 inhibitory activity is a 111 secreted, metal-dependent protein. Two secreted proteases from E. faecalis are well 112 known, the serine protease SprE and the metalloprotease GelE, both of which are 113 regulated by the two-component, quorum-sensing fsr (faecalis system regulator) operon 114 (9) (Figure 2A) . We obtained strains of E. faecalis containing null mutations in sprE 115 (TX5243), gelE (TX5264), fsrB (TX5266), and a gelE, sprE double mutant (TX5128), all 116 generated in the commonly used wild-type OG1RF E. faecalis strain (10). To test the 117 GLP-1 inhibitory activity of these strains, supernatants were incubated directly with 118 recombinant GLP-1 (Tocris) (Figure 2B ). Of the strains tested, only the DsprE strain 119 maintained GLP-1 inhibitory activity equal to that of wild-type OG1RF (OG1RF -0.06% ± 120 insulin, IL-6, tumor necrosis factor alpha (TNFa), and monocyte chemoattractant 142 protein-1 (MCP-1)) and quantified by a Luminex assay. From our findings, GelE is 143 capable of degrading, to some extent, nearly all the substrates tested in the metabolic 144 panel (Figure 4) ; however, some patterns of degradation emerged. Recapitulating our 145 previous findings, GLP-1 levels were reduced to 0.57% ± 0.13, down to the limit of 146 detection of the assay. Similar degradation was observed for GIP, glucagon, leptin, 147 PYY, and pancreatic peptide. For insulin, MCP-1, and TNFa, degradation was less 148 striking, but still statistically significant. Finally, we did not observe consistent 149 degradation of IL-6 by GelE. 150
To gain a better understanding of the substrate preference of GelE, we also 151 tested the ability of diluted supernatants of E. faecalis 30054A, from 1-0.0001X, to 152 degrade the same panel of metabolic substrates ( 
Interaction of GelE and GLP-1 through an epithelial layer 166
While GelE from E. faecalis may readily cleave GLP-1 and other substrates in 167 vitro, it is important to consider the GI epithelium separating these two molecules in 168 vivo. Previous work has implicated E. faecalis, and specifically GelE, in contributing to 169 intestinal epithelium disruption (13-15). We aimed to model the ability of GelE to contact 170 GLP-1 through an epithelial layer using T84 epithelial cells in a transwell format, to 171 mimic the microbial interface on the apical side and the presence of GLP-1 on the 172 basolateral side of the epithelium (Figure 5A) . The integrity of the T84 epithelial layer, 173
as measured by transepithelial electrical resistance, decreased by approximately half 174
with the apical addition of cell-free E. faecalis supernatants expressing GelE, 30054A 175 and OG1RF (52.2% ± 17.97, p = 0.0022 and 65.5% ± 9.47, p = 0.0439, respectively, 10 lacking GelE, DgelE and S613, increased the integrity of the epithelial layer (156.6% ± 178 24.76, p = 0.0045 and 153.7% ± 18.93, p = 0.0084, respectively, compared to 179 DMEM/F12 T84 cell culture media control) (Figure 5B) . Our data from Luminex assays using a panel of metabolic substrates show that 208
GelE is able to degrade more substrates than previously suspected, and furthermore, 209
that GelE has an enhanced ability to degrade some substrates over others, including Interestingly, the Enterococcus genus has been linked to obesity in children and 247 adolescents, as well as to mice consuming a western diet (21, 22). While not 248 characterized in this study, we also identified several Clostridium isolates whose 249 supernatants are capable of decreasing GLP-1 levels in vitro. We suspect this activity is 250 also the result of a secreted protease cleaving GLP-1, supporting the idea that the 251 microbiome produces a suite of proteases capable of interfering with host metabolism. 252
Although E. faecalis and Clostridium have been implicated in infection, but they can also 253 behave as commensal organisms and often live inconspicuously in our GI tracts. It is 254 important to understand all the interactions of these organisms with their host, not just 255 the overt pathogenic functions. 256
In summary, the results of this study demonstrate that GelE, a recognized 257 
Bacterial growth and preparation of cell-free supernatants 277
Bacterial isolates were streaked from frozen glycerol stocks onto GM17 agar 278 plates and incubated anaerobically overnight at 37°C. One colony was inoculated into 5 279 mL of GM17 broth and incubated overnight at 37°C followed by one more subculture 280 into GM17 broth, and incubation overnight at 37°C. Once grown, bacterial cultures were 281 centrifuged at 5000 x g for 20 min. Supernatants were collected and lyophilized 282 (Labconco Freezone), followed by storage at -80°C until used for subsequent assays. 283
284

16S rRNA gene sequencing of isolates 285
To identify the bacterial isolates, bacteria were streaked on GM17 (M17 + 0.5% 286 (w/v) glucose) agar plates from frozen glycerol stocks and incubated at 37°C for 24-48 287 h. Bacterial colony mass was then resuspended in 800 µL of sterile water and 288 transferred to sterile bead beating tubes and homogenized for 2 min in a mini-289 beadbeater-96 (Biospec Products). Tubes were centrifuged at 8000 xg for 30 sec and 290 supernatants were used for 16S rRNA gene PCR amplification with Phusion High-291
Fidelity DNA Polymerase (New England Biolabs) in a 20 µL reaction according to the 292 manufacturer's protocol, with sequencing primers 8F and 1492R. The amplification 293 cycle consisted of an initial denaturation at 98°C for 30 sec, followed by 26 cycles of 10 294 sec at 98°C, 20 sec at 51°C, and 1 min at 72°C. Amplification was verified by agarose 295 gel electrophoresis. For sample cleanup, DNA was treated with Exo-SAP-IT 296 (ThermoFisher) and incubated at 37°C for 15 min followed by a 15 min incubation at 297 80°C to inactivate the enzyme. The product was cooled and sent to Genewiz for 298 sequencing according to company protocol. Upon return of sequencing data, sequences 299 were compared to the NCBI BLAST database. overnight, supernatants were collected as described above, and incubated with 500 pM 325 GLP-1 (GenScript) for 4 h at room temperature, followed by storage at -80°C until ready 326
for GLP-1 quantification by ELISA. 327
For heat treatment studies, bacterial supernatants were heated to 90°C for 30 328 min. Samples were then used in an NCI H716 cell assay as described above, followed 329 by storage at -80°C until ready for GLP-1 quantification by ELISA. 330
For size fractionation studies, bacterial supernatants were separated by size 331 using centrifugal filter units (Amicon) and centrifuged as described above. Samples 332 were then used in an NCI H716 cell assay as described above, followed by storage at -333 80°C until ready for GLP-1 quantification by ELISA. 334
335
Protease knock-out studies 336
Supernatants from E. faecalis protease mutants and controls (OG1RF, TX5266 337 (fsrB), TX5264 (gelE), TX5243 (sprE), TX5128 (gelE;sprE)) were collected from an 338 overnight culture grown in GM17 aerobically at 37°C by centrifugation as described 339 above. Supernatants were incubated with 500 pM GLP-1 (Tocris or GenScript) for 4 h at 340 room temperature, followed by storage at -80°C until ready for GLP-1 quantification by 341 ELISA, as described above. Growth and assays of T84 cells were performed by methods described 359 previously, with slight modifications (Zeng 2004 , Hopper 2000 . T84 human colonic 360 epithelial cells (ATCC CCL-248) were propagated in tissue culture-treated T75 flasks 361 were treated with 0.25% trypsin and plated onto 24-well, 3.0 µm polycarbonate 363 membrane transwell filters (Costar, 3415) at a density of 8 x 10 4 cells/well. The electrical 364 resistance of the monolayer was monitored over the course of 2-3 weeks, and 365 monolayers with a transepithelial electrical resistance (TEER, Millipore Millicell ERS-2) 366 >800 W/cm 2 were used for GLP-1 cleavage assays. 367
To prepare bacteria, on the day of the assay E. faecalis strains were subcultured 368 1% (v/v) from an overnight culture into GM17 and grown for 5 h as described above. 369
Whole culture (cells + supernatant) samples were diluted in DMEM/F12 (Gibco) to a 370 concentration of 1 x 10 7 CFU/mL, and supernatant samples were diluted 50% in 371 DMEM/F12. All samples were neutralized to a pH of 6.8-7 using 3M NaOH. 372
Once prepared, the TEER was measured for each monolayer, followed by 100 373 µL of E. faecalis sample added to the upper chamber of the transwell, and 500 µL of 374 tissue culture media containing 500 pM GLP-1 (GenScript) added to the lower chamber. 375
After a 16 h incubation at 37°C in 5% CO2, 200 µL of media from the lower chamber 376 was removed and stored at -80°C until ready for GLP-1 quantification by ELISA, as 377 described above. A final TEER measurement was taken for each monolayer. factor alpha (TNFa). Bacterial supernatants were collected from an overnight culture by 385 centrifugation as described above, diluted in bacterial culture media as indicated, and 386 incubated with recombinant protein (GenScript, Sigma, Tocris) of each analyte for 4 h at 387 room temperature, followed by storage at -80°C until ready for analyte quantification. 388
The Milliplex Multiplex assay was run according to the protocol provided by the 389 manufacturer. 390 391
Statistical analysis 392
Statistical analyses were performed using GraphPad Prism version 8.0 (San 393 Diego, CA, USA). Experimental results are expressed as means ± standard deviation. 394
Statistical significance was set at p < 0.05. One-way statistical comparisons were 395 carried out using one-way analysis of variance (ANOVA), followed by multiple 396 comparisons of the means using Tukey's post-hoc analysis, for the GLP-1 secretion 397 experiments in NCI-H716 cells, protease knock-out mutation assay, and degradation 398 preference of GelE using a Luminex assay (undiluted supernatants). Two-way ANOVA 399 analysis, followed by multiple comparisons of the means using Tukey's post-hoc 400 analysis, was performed for the degradation preference of GelE using a Luminex assay 401 (diluted supernatants) and T84 cell experiments. 
